Independent peptide education · Evidence annotated · Research use information
Peptide Library / AICAR

AICAR Research Guide

AMPK-related experimental nucleotide analog

Preclinical and experimental
ClassificationSingle Peptide
Evidence tierPreclinical and experimental
Research statusEducational reference
01 · At a glance

Overview

AICAR is included in this independent research library to separate what has been demonstrated from what remains theoretical. The evidence, regulatory status and terminology vary substantially by compound, so claims should be read in the context of the cited literature.

Dosing & reconstitution guide

AICAR suggested dosing guide

A concise reference to the dosing ranges most often used in approved labeling, clinical research, or published research discussions. Evidence strength is shown so established dosing is not confused with experimental protocol.

Research protocol only
Suggested starting rangeNo established human therapeutic dose
Typical reference rangeNo validated human dosing range
FrequencyNot established
TimingNot established
Typical durationNot established
RouteResearch route varies

Titration and protocol notes

AICAR is an experimental small molecule and prohibited in sport by WADA.

Annotated dosage protocol

Each row explains what the dosage represents. Read it with the evidence badge above: labeled doses, clinical-trial doses, and commonly discussed research amounts do not carry equal clinical weight.

PhaseDoseScheduleWhat this dosage means
Lower referenceNo established human therapeutic doseNot establishedThe lower end reported in research discussions; it is not a validated human starting prescription.
Commonly cited rangeNo validated human dosing rangeNot establishedA range repeated in reference protocols. Repetition does not establish safety, efficacy, or an approved regimen.
Duration / reassessmentNot establishedReassess before continuingAICAR is an experimental small molecule and prohibited in sport by WADA. Dose changes should never be inferred from vial size or convenient syringe units.

AICAR reconstitution example

This worked example uses a 50 mg vial, 2 mL of diluent, and a 1 mg reference amount.

Vial strength50 mg
Diluent added2 mL
Concentration25 mg/mL
Example draw0.04 mL / 4 units
How this example is calculated: 50 mg ÷ 2 mL = 25 mg/mL. The 1 mg reference amount equals 1 mg. That produces a 0.04 mL draw, or 4 units on a U-100 syringe.

Syringe units assume a U-100 syringe. Always verify the vial label, syringe type, formulation, and arithmetic independently.

Safety, handling, and storage
  • Suggested ranges are educational summaries, not individualized prescriptions.
  • FDA-labeled regimens apply only to the approved product, indication, and delivery system.
  • For experimental compounds, human safety, purity, and effective dosing may be unknown.
  • Follow product-specific sterility, storage, and beyond-use instructions; do not use damaged or contaminated material.
Live concentration math

AICAR calculator

Enter your laboratory values to calculate concentration, draw volume, syringe units, and portions per vial.

Runs in your browser
Concentration25 mg/mL
Draw volume0.04 mL
On the syringe4 units
Portions per vial50

Deterministic arithmetic for laboratory documentation only. This tool does not select a dose, provide a protocol, or replace qualified medical or laboratory guidance.

02 · How it is studied

Mechanism and research rationale

Not a peptide. After cellular uptake it can be converted to ZMP, an AMP mimetic used experimentally to study AMPK-linked metabolism.

AMPK signaling

Cellular energetics

Exercise models

03 · Interpretation

Key facts

  • Evidence tier: Preclinical and experimental.
  • Research status and regulatory status are not interchangeable.
  • This page is an educational reference and does not provide personal medical instructions.
04 · Editorial annotations

What to keep in mind

Editorial note: distinguish peer-reviewed findings from supplier or community claims.
Evidence note: study design, species, route and formulation can materially change interpretation.
05 · Sources

References and evidence indexes

  1. PubMed search: AICAR
  2. ClinicalTrials.gov search
Research notice: This guide is educational and not medical advice. It does not diagnose, treat, prescribe, or recommend personal use.